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Abstract
The genome of human immunodeficiency virus (HIV) has an average nucleotide composition strongly biased as compared
to the human genome. The consequence of such nucleotide composition on HIV pathogenicity has not been investigated
yet. To address this question, we analyzed the role of nucleotide bias of HIV-derived nucleic acids in stimulating type-I
interferon response in vitro. We found that the biased nucleotide composition of HIV is detected in human cells as
compared to humanized sequences, and triggers a strong innate immune response, suggesting the existence of cellular
immune mechanisms able to discriminate RNA sequences according to their nucleotide composition or to detect specific
secondary structures or linear motifs within biased RNA sequences. We then extended our analysis to the entire genome
scale by testing more than 1300 HIV-1 complete genomes to look for an association between nucleotide composition of
HIV-1 group M subtypes and their pathogenicity. We found that subtype D, which has an increased pathogenicity compared
to the other subtypes, has the most divergent nucleotide composition relative to the human genome. These data support
the hypothesis that the biased nucleotide composition of HIV-1 may be related to its pathogenicity.
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Introduction
Without treatment, most individuals infected with HIV will
develop AIDS as a consequence of years of chronic and excessive
activation of their immune system [1]. The generalized immune
activation in AIDS consists in over expression of activation
markers, excessive proliferation and apoptosis of CD4 and CD8 T
cells, NK cells, B cells and macrophages, in addition to a strong
type I interferon response, which is maintained throughout the
chronic phase of infection [2]. Because the virus replicates
preferentially in activated CD4 T cells, chronic activation supports
viral replication by providing targets. A number of mechanisms
have been suggested to contribute to immune activation in AIDS
pathogenesis [3,4], such as i) the innate and adaptive response to
HIV and its antigens, ii) the direct effect of viral proteins on cell
receptors like Env-CD4/CCR5 or TCR down-regulation by Nef,
iii) the activation of TLRs by microbial products leaking from the
damaged gut mucosa, iv) the frequency of opportunistic infections,
v) increased levels of proinflammatory and pro-apoptotic cyto-
kines, vi) depletion of CD4 T regulatory cells.
Viral nucleic acids trigger an antiviral innate immune response
in infected cells, which contributes to activating the immune
system [4,5,6]. Cytoplasmic accumulation of HIV nucleic acids
has been shown to be responsible for the majority of T-cell
apoptosis during HIV infection [7]. IFN-a/b is the principal
mediator of antiviral innate immunity. Different forms of viral
RNA molecules can trigger IFN-a/b stimulation, either single or
double stranded, naked or combined with capsid proteins
[8,9,10,11]. Several cytosolic receptors have been identified that
recognize HIV-1 patterns [12,13]. Plasmacytoid dendritic cells
(pDCs) produce large amounts of IFN-a/b in response to
microbial stimuli. During the acute phase of HIV infection, pDCs
are the main producers of IFN-a/b. They recognize viral ssRNA
via TLR7, and dsDNA via TLR9 [14,15]. This antiviral response
contributes to containing the acute infection. In primate models of
lentiviral infection, pDCs produce large amounts of IFN-a/
b during the acute phase of infection, whatever a pathogenic or
non-pathogenic outcome [4,6]. However, during the chronic
phase of infection, viral RNA, which is still produced in infected
cells, stimulates IFN-a/b production on the long term. A recent
study reported that in chronically HIV-infected patients IFN-
a colocalized only with few pDCs, but rather with other TLR7
negative cells [16].
The genomes of HIV and most lentiviruses present a particularly
biased nucleotide composition compared to that of their primate
hosts, with as much as 35% adenosine in HIV-1 RNA genome. As
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e33502a consequence, the average amino acid composition is different
and the synonymous codon usage is also modified [17,18].
Lentiviral biased nucleotide composition has been explained by
dNTP pool imbalance during reverse transcription [19,20] and by
the antiviral activity of the cellular Apobec 3G (A3G) cytidine
deaminase, which mutates G to A in HIV provirus [21] thus
impacting HIV-1 evolution and drug resistance [22,23], although
the counteracting activity of the viral Vif protein reduces Apobec
impact on the nucleotide bias of HIV genome [20].
Such biased nucleotide composition obviously has direct
consequences on genome structure and stability, but its effects
on viral biology have not been investigated yet. We wondered
whether the strongly divergent nucleotide composition of HIV-1
nucleic acids, as compared to host, plays a role in triggering
antiviral innate response. To address this question, we compared
the capacity of HIV-1 RNA molecules corresponding to the
three major viral genes, either wild type or artificially unbiased,
to modulate IFN-a/b synthesis in a sensitive in vitro assay in
human cells. We also tested a set of small RNA fragments
covering the entire HIV-1 genome for their capacity to activate
IFN-a/b response according to their nucleotide composition. We
then performed a large-scale bioinformatics study to compare the
divergence in nucleotide composition between all subtypes of
HIV-1 group M viruses. Altogether, this work shows that AU-
rich biased HIV-1 sequences, mainly located within gag, pol, env
genes, strongly stimulate IFN-a/b response, and that HIV-1
subtype D, which has an increased pathogenicity, has a more
biased sequence.
Results
The Biased Nucleotide Composition of HIV-1 RNA
Stimulates IFN-a/b Synthesis
To first analyze the divergence between HIV and human
nucleotide composition, we plotted the distribution of human
coding sequences according to their length and nucleotide
divergence, as measured by the Chi-square distance relative to
average nucleotide A/C/G/T frequency of all human coding
sequences (Figure 1). This analysis shows that the majority of
human coding sequences are gathered in a group of relatively
small size sequences with homogenous nucleotide composition.
Comparing in the same analysis HIV-1 nucleotide composition to
the human genome highlights that gag, pol, env and vpu genes are
highly divergent from human sequences (black dots in Figure 1).
To investigate the role of such biased nucleotide composition of
HIV genome on immune activation, we analyzed the ability of
HIV-1-derived RNA fragments, whose nucleotide sequence was
either wild type (WT) or artificially optimized to human codon
usage, to induce IFN-a/b synthesis in vitro in epithelial-like HEK
293 T cells (ATCC, CRL-11268). We chose these cells because
they are easily transfectable and produce IFN-a/b in response to
HIV-1 infected cells although they lack TLR7 [13]. The three
major HIV-1 genes gag, pol, env (gag, pol from hxb2 sequence and env
from a primary isolate sequence) and their corresponding versions
optimized towards human codon bias (Gag opt, Pol opt, Env opt)
were in vitro transcribed with T7 RNA polymerase into uncapped
and unpolyadenylated RNA fragments. These RNA fragments
were co-transfected into HEK 293 T cells together with a reporter
plasmid containing the luciferase gene fused downstream of five
interferon-stimulated response elements (ISRE-luciferase). A low
amount of a plasmid harboring a thymidine kinase (Tk) promoter
just upstream of the renilla luciferase gene was also co-transfected
to allow normalization between wells. In a first set of experiments,
we performed a dose-response analysis for each RNA molecule
tested to determine the highest non-toxic dose that did not affect
the level of renilla expression. A unique dose of 20 ng that was not
toxic and did not affect, or only moderately, transfection efficiency
was chosen for transfecting all RNA fragments (Figure S1). The
reporter activity, reflecting the induction of IFN-a/b response, was
calculated as the ratio of firefly luciferase activity to reference
renilla luciferase activity measured in cell lysates 20 hours after
transfection (Figure 2A). While the WT versions of Gag, Pol or
Env RNAs induced a strong IFN-a/b expression, this capacity was
abolished in their humanized versions, which induced very low
levels of IFN-a/b. Although both type of sequences shared the
same coding information, transfecting uncapped and unpolyade-
nylated RNA molecules in this experiment allowed evaluating the
role of RNA molecules in the absence of expressed proteins.
Moreover, to ensure that no protein is expressed from RNA, we
deleted the first nucleotide of the AUG codon in each construct.
The nucleotide composition of wild type and humanized HIV-1
RNA fragments used in this experiment reveals that humanization
results essentially in reducing A/U and increasing G/C contents
(Figure 2B). Our observation demonstrates that the biased
nucleotide composition of HIV synthetic RNA molecules, or its
structural consequence, is detected in human cells and triggers
a strong innate immune response.
A-rich Regions of HIV-1 Genome are Responsible for IFN-
a/b Stimulation
To investigate whether shorter specific regions within HIV-1
genome are responsible for IFN-a/b stimulation, we first looked
for hyper-biased region on the whole genome. For that, we
computed the Chi-square distance between the A/C/G/U
frequencies of a sliding window 500 nt wide along the genome
of HIV-1 clone hxb2 and the corresponding frequencies of the
Figure 1. Most HIV-1 genes are divergent from human coding
sequences. The distribution of human coding sequences is represent-
ed according to their length (log scale) and nucleotidic divergence, as
measured by the Chi-square distance relative to average composition of
all human coding sequences. The colored background shows the
density of human coding sequences as indicated on the z-scale. Black
dots represent either single HIV-1 genes or the entire HIV-1 genome.
Note the distinguishable positions of the gag, pol, env and vpu genes.
doi:10.1371/journal.pone.0033502.g001
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expected from Figure 1, we found the most divergent regions
located within the three large viral genes (gag, pol, env), while
overlapping coding regions and cis-active regulatory sequences are
unbiased. Since adenosine enrichment contributes to most of the
divergence (red line in Figure 3A), these ‘‘hot spots’’ of divergence
are likely the footprint of adenosine accumulation during low-
fidelity reverse transcription and by the action of cytidine
deaminases. This highlights that the long open reading frames
(ORF) of lentiviruses (gag, pol, env) can accumulate more
synonymous mutations than the rest of the genome without
impairing viral fitness. They reflect the tendency of lentiviral
genomes to become A-rich through evolution [24].
To determine then the local distribution of immune activating
sequences along the viral genome, we measured the ability of a set
of RNA fragments covering the entire genome of HIV-1 clone
hxb2 to induce IFN-a/b synthesis in vitro in the same system as used
above. We generated 38 PCR fragments of approximately 500 bp,
with overlaps of 250 bp, and covering the entire genome of HIV-1
hxb2 (primers used are listed in Table S1). These DNA fragments
were in vitro transcribed with T7 RNA polymerase into a set of
overlapping uncapped and unpolyadenylated RNA fragments.
The quality and integrity of RNA fragments was controlled by
migration on electrophoresis chips (Figure 4). These RNA
fragments were co-transfected into HEK 293 T cells together
with the reporter ISRE-luciferase plasmid, and luciferase activity
was measured 20 h after transfection. Again, we performed a dose-
response analysis for each RNA molecule to determine the highest
non-toxic dose that did not affect the level of renilla expression. A
unique dose of 12 ng that was not toxic and did not affect
transfection efficiency was chosen for transfecting all RNA
fragments (Figure S1). The ability of each fragment to induce an
interferon response, calculated as the ratio of firefly luciferase
activity to reference renilla luciferase activity (Figure 3B), was
compared to its divergence in nucleotide composition with the
human genome composition (Figure 3A, black line). The
comparison highlights that RNA fragments that have the greatest
divergence in nucleotide composition (mainly due to adenosine
enrichment) are the most potent stimulators of IFN-a/b response
(Figure 3C, p = 1.3 10
25, Pearson correlation test, R
2 = 0,41).
Although the p-value of this correlation is very strong, some
fragments do not follow the global trend, particularly within the pol
gene where 4 fragments located in regions of high nucleotide
divergence appear to be low inducers of IFN-a/b response.
Because the design of primers for the synthesis of RNA fragments
was arbitrary (approximately every 500 bp), outliers may result
from the elimination of either a secondary structure or a linear
motif necessary for recognition in the host cell. Altogether, these
results demonstrate that the most biased HIV RNA sequences are
responsible for IFN-a/b stimulation.
Subtype D is the Most Divergent Among HIV-1 Group M
Viruses
To investigate the possible influence of the biased nucleotide
composition of HIV RNA in AIDS pathogenesis, we looked for an
association between nucleotide composition of HIV-1 group M
subtypes and their pathogenicity. Different studies recently
reported that among HIV-1 group M subtypes, infection with
subtype D is associated with a significantly faster CD4 cell decline
than other subtypes [25,26,27,28], thus indicating an increased
pathogenicity of subtype D viruses. Many reasons may account for
this increased pathogenicity, such as virus replicative capacity or
escape to immune responses. To look for an association with
nucleotide bias, we measured the divergence of nucleotide
composition between all HIV-1 subtypes and human genome by
computing the Chi-square distance between the A/C/G/U
frequencies of more than 1300 HIV-1 complete genomes and
the entire coding sequences of human genome (Figure 5). All HIV-
1 group M ‘‘pure’’ subtypes, for which more than 20 genomic
sequences are available in Los Alamos database (clade A, B, C, D,
F & G), were used in this analysis. We first evaluated the
divergence between all subtypes by using ANOVA test. Looking
blindly among the subtypes highlights that at least one subtype is
significantly more biased and more divergent relative to human
genome than the others (p=2.10
26). We then used the Student t-
test to compare subtype D divergence relatively to all other
subtypes pooled together. It appears that subtype D is significantly
more divergent to human genes than all other subtypes
(Bonferroni-corrected Student t-test, p=3.10
25). The observation
that the most pathogenic HIV-1 subtype is also the most divergent
in nucleotide composition with human genome is a preliminary
indication of a possible contribution of HIV-specific nucleotide
bias in AIDS pathogenesis. Detecting this effect through large-
Figure 2. Humanization of HIV-1 genes strongly reduces their ability to induce IFN-a/b. (A) Type-I interferon stimulation was measured as
the ISRE-dependant expression of luciferase activity in HEK 293 T cells upon transient transfection of HIV-1-derived RNA molecules. The ISRE reporter
activity is the ratio of firefly luciferase activity to control renilla luciferase activity in triplicate experiments. In vitro transcribed RNA molecules
corresponding to the wild type sequence of the three HIV-1 major genes induced a strong response while their humanized version induced a tenfold
lower response. (B) Nucleotide composition of HIV-1 RNA fragments expressed as the A/C/G/U frequencies.
doi:10.1371/journal.pone.0033502.g002
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mechanism involved is disseminated along the HIV-1 sequence.
Discussion
Very little is known about the consequences of the biased
nucleotide composition of human immunodeficiency viruses on
their pathogenicity. In this report we addressed this question by
analyzing the role of nucleotide composition of HIV-1-derived
nucleic acids in stimulating IFN-a/b response, then by correlating
the pathogenicity of HIV-1 M subtypes with the divergence of
their nucleotide composition with human coding sequences.
To measure type-I IFN stimulation, we used an in vitro assay
allowing to discriminating the role of RNA nucleotide composition
Figure 3. The nucleotidic divergence of HIV-1 RNA fragments correlates with their ability to stimulate IFN-a/b.A ) The black line shows
the nucleotide divergence of HIV-1 compared to human genome, as measured by a Chi-square distance in a 500 bp sliding window along the HIV-1
hxb2 genome. The individual contributions of A, C, G, and U nucleotides to this divergence are shown respectively in red, blue, yellow and green. The
HIV-1 genome map is schematically represented above the figure. B) Histogram represents the ISRE reporter activity as the ratio of firefly luciferase
activity to control renilla luciferase activity determined in HEK 293 T cells cotransfected with HIV-1 RNA fragments and pISRE-Luc reporter. C)
Correlation between the nucleotide divergence (x-axis) and the luciferase activation (y-axis) of the 38 RNA fragments from HIV-1 hxb2 genome. Each
point corresponds to the average of four replicates and the correlation coefficient was computed only on these averages to not artefactually lower
the p-value.
doi:10.1371/journal.pone.0033502.g003
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biased nucleotide composition of HIV RNA is detected in human
cells and triggers a strong innate immune response. We evidenced
that HIV-1-derived RNA molecules that are the most biased in
their nucleotide composition as compared to human coding
sequences are the most potent IFN-a/b stimulators. They
correspond to the three main viral genes, which are the most
abundant viral RNA molecules in the cytoplasm of infected cells
during HIV viral production. Optimization of these sequences to
human codon bias, and therefore to human A/C/G/U frequency
abolished their stimulating capacity. Similarly, discrete fragments
of 500 bp within HIV-1 genome stimulate type-I IFN according to
their nucleotide composition, the most biased being the best
stimulators. These results indicate the existence of a molecular
mechanism capable of sensing the biased nucleotide composition
of RNA molecules or its structural consequence, or the presence of
A-rich linear motifs, such as instability elements for example.
Several receptors may discriminate nucleic acids according to their
nucleotide composition. HIV encodes multiple U-rich sequences
recognized by Toll-like receptor 7/8 [29]. Cytosolic AT-rich DNA
can be transcribed by RNA pol-III into RNA molecules that
induce IFN-a/b through the RIG-I pathway [30]. In the HCV
genome, RIG-I preferentially binds poly-U/UC, poly-U/UG and
poly-A RNAs [31]. RIG-I is also able to trigger IFN-a/b response
in the presence of genomic RNA extracted from HIV-1 particles
[32]. Other hypotheses can be formulated, such as the formation
of RNA secondary structures specifically recognized by innate
immunity sensors, or the recognition of specific AU-rich linear
motifs. Finally, sequence specific RNAse such as RNAse L could
also increase the innate immune response against AU-rich RNAs
[33].
Whether this nucleotide bias is detected in infected natural
target cells and contributes to activating immune system in HIV
patients is unknown. Therefore, we looked for an association
between nucleotide composition of HIV-1 subtypes and their
pathogenicity. To investigate whether HIV-1 subtype nucleotide
composition, and particularly its divergence with the human
genome, is associated with differential pathogenicity, we combined
information from numerous HIV-1 complete genomes and from
large-scale epidemiological studies [25,26,27,28]. We observed
that subtype D, which cause a faster CD4 cell decline, is
significantly more divergent from the human genome than other
subtypes. This observation supports the assumption that the higher
capacity of biased HIV-1 nucleic acids to stimulate IFN-a/
b synthesis may be linked with immune activation and
pathogenesis. Although several other factors may determine the
pathogenicity of a given HIV-1 subtype, such as replicative
capacity, ability to escape adaptive immune response, restriction
factors [12,34], our data suggest that the strength of host innate
immune response and its adaptation to viral nucleotide compo-
sition is critical.
To further extend this observation and determine whether the
aggressive nucleotide composition of other lentiviruses than HIV-1
is linked to pathogenicity, it is of interest to look at non-human
primate models for which SIV chronic viral infection is associated
with either pathogenic or non-pathogenic outcome. Indeed,
persistent infection by a highly replicating lentivirus does not
necessarily lead to AIDS, and natural hosts such as African green
monkeys (AGM), sooty mangabeys (SM) and mandrills (Mnd),
never develop chronic immune activation and do not progress to
AIDS, despite chronic high viremia [35] [4]. Conversely,
experimental transmission of the SM type of SIV (SIVsm) to
rhesus macaques (RM), or of SIVagm.ver90 and SIVagm.sab92018
Figure 4. Overlapping RNA fragments covering the entire genome of HIV-1 hxb2. PCR fragments of approximately 500 bp, with overlaps of
250 bp, and covering the entire genome of HIV-1 hxb2 were in vitro transcribed with T7 RNA polymerase into a set of uncapped and
unpolyadenylated RNA fragments. After purification RNA fragments were migrated on Agilent-2100 Small RNA chips. A ladder on the left indicates
the size in nucleotides.
doi:10.1371/journal.pone.0033502.g004
Figure 5. HIV-1 subtype D has the most divergent sequence.
Boxplots show the median and dispersion of the nucleotide divergence
of individual HIV-1 genomes from different subtypes to the average of
human coding sequences. Red stars indicate that D subtype is
significantly more divergent than other subtypes (p=2610
26 ANOVA
test, p=5.8610
26 Student t-test, p=2.8610
27 Wilcoxon test). The
random 10 kb column shows the median and standard deviation of the
divergence between 10 kb of random human coding sequences and
the average of all human coding sequences; 95% of the points have
a divergence below 0.03, and less than 1% of the points are above 0.05,
ie comparable to HIV divergence. Standard deviation gives a natural
scale of variation to the graph. These data were not used in the
statistical procedure to compare subtypes.
doi:10.1371/journal.pone.0033502.g005
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gression to AIDS [36]. It may thus be hypothesized that
interspecies transmission of SIV results in immune hyper-
activation within new hosts, whereas natural hosts, in which the
infection has long been established, tolerate the virus and control
the homeostasis of their immune system. Analyzing the nucleotide
divergence of different SIV strains with their primate hosts would
be useful in this context. However, although numerous SIV
complete genomes are available, only three primates complete
genomes have been published (human, chimpanzee and rhesus
macaque) and large-scale genomic sequences from natural SIV
hosts primates, in which infection is non-pathogenic, are quite rare
while they would provide a crucial input. We are currently
working on such analyses.
In conclusion, our observations suggest for the first time that the
specific nucleotide composition of HIV-1 genome might have
a consequence on its pathogenicity. They suggest the existence of
cellular immune mechanisms able to discriminate RNA sequences
according to their nucleotide composition or to detect specific
secondary structures or linear motifs within biased RNA
sequences. These observations are valid at intra-genome and
between-genome scales, indicating that the causative mechanism
they involve is disseminated along the HIV-1 sequence, and
therefore can only be detected through large-scale comparative
genomic studies. Our observations also lead to readdress the
antiviral role of RNA editing enzymes such as cytidine deaminases
[37]. In the case of A3G, increasing the A/U content of lentiviral
genomes makes the viral RNAs more divergent. The resulting
sequences, if still able to replicate, would activate the innate
immune response to a higher extent. During co-evolution between
a lentivirus and its host, this mechanism might help the immune
system to reinforce the discrimination between self and non-self to
preserve the organism, counterbalancing the humanization of viral
genome due to nucleotidic pool constraints in the host cell [19,20].
Intriguingly, this mechanism might also contribute to maintaining
or increasing the virus pathogenicity. Although further work is
necessary to confirm this observation in non-human primate
models of SIV infection, highlighting the role of lentiviral
nucleotide composition may help in understanding lentiviral
pathogenesis and in AIDS vaccine design.
Materials and Methods
RNA Preparation
Primers (Table S1) were designed to amplify 38 overlapping
fragments of around 500 pb long by PCR reaction (Enzyme
Phusion, 35 cycles, Ta=60uC, 30 sec. elongation). Primers were
also designed to amplify sequences (1 min. elongation) from Gag,
Pol or Env from HIV-1 clone hxb2 or from plasmid expressing
codon-optimized sequences of the genes. Gag optimized gene was
purchased from Genecust, Pol and Env genes were purchased to
Geneart. A 59 tail containing the sequence of T7 promoter was
included in every forward primer to allow the subsequent in vitro
transcription reaction. PCR products were purified and used as
template for T7 RNA synthesis according to manufacturer’s
instructions (T7 RiboMA Express, Promega). Resulting RNA were
purified using RNeasy mini kit (Qiagen) and concentration was
determined by nanodrop measurement. RNA quality and integrity
was controlled using Agilent-2100 Bioanalyzer prior to cell
transfection.
Luciferase Reporter Gene Assay
Expression of IFN-a/b was determined by transient transfection
of reporter plasmids pISRE-Luc containing five ISRE enhancer
elements upstream of the firefly luciferase gene (Stratagene). HEK
293 T cells (ATCC, CRL11268) were plated in 24-well plates
(2610
5 per well). One day later, cells were transfected using 1 ml
of Lipofectamine 2000 (Invitrogen) with pISRE-Luc reporter
plasmid (250 ng/well), a plasmid harboring a thymidine kinase
(Tk) promoter just upstream of the renilla luciferase gene (25 ng/
well), and 12 ng of each RNA fragment (500 pb) or 20 ng of Gag,
Pol or Env (hxb2 or optimized). After 20 h, cells were lysed, and
the firefly and renilla luciferase activities were measured in cell
lysates using the Dual-luciferase Reporter Assay System (Promega)
according to manufacturer’s instructions. Reporter activity was
calculated as a triplicate of the ratio of firefly luciferase activity to
reference renilla luciferase activity.
Data and Statistical Analyses
Chi-square distances between the nucleotide frequencies of
HIV-1 and the human genome were computed by:
d~
X(fhost{fvirus)
2
fhost
The estimate of the nucleotidic composition of the human
genome was computed on all coding sequences. For HIV-1, the
entire genome of the hxb2 clone (HIVHXB2CG) was used for the
frequencies estimation. All HIV-1 sequences from different
subtypes (more than 1300) were downloaded from the HIV
database (www.hiv.lanl.gov). Statistical procedure in the analysis of
these data involved first an ANOVA to detect a difference between
subtypes, followed by a Student t-test to compare subtype D
relatively to all others subtypes pooled together. Bonferroni
multiple test correction was applied. The correlation between
Luciferase reporter activity and host/virus nucleotide divergence
was computed using the nucleotide frequencies of each 500 bp
RNA fragment using standard linear correlation test. Density of
human genes of given length and nucleotidic divergence relative to
the average of all human coding sequences (Fig. 1) was computed
using a standard 2-dimensional gaussian kernel. All analyses were
done using the R software.
Supporting Information
Table S1 HIV-1 primers used in Figures 3 and 4.
(DOC)
Figure S1 Efficiency of HEK 293T cells transfection in
presence of HIV-1 RNA fragments. RNA was co-transfected
with a reporter ISRE-firefly luciferase plasmid and a plasmid
harboring a thymidine kinase promoter upstream the renilla
luciferase gene in triplicate experiments. As a control of trans-
fection efficiency, the renilla luciferase activity was measured in
cell lysates 20 hours after transfection. The different RNA
fragments used are indicated.
(TIF)
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